Giriş

Bu sayfada, Reshma Kewalramani için bilinen içeriden öğrenen ticareti geçmişinin kapsamlı bir analizi sunulmaktadır. İçeriden öğrenenler bir şirketteki yetkililer, yöneticiler veya önemli yatırımcılardır. İçeridekilerin belirli, kamuya açık olmayan bilgilere dayanarak şirketlerinin ticaretini yapması yasa dışıdır. Bu onların kendi şirketlerinde herhangi bir işlem yapmalarının yasa dışı olduğu anlamına gelmez. Ancak tüm işlemleri Form 4 aracılığıyla SECe bildirmeleri gerekiyor. Bu kısıtlamalara rağmen, akademik araştırmalar içerdekilerin genel olarak kendi şirketlerinde piyasadan daha iyi performans gösterme eğiliminde olduklarını gösteriyor.

Ortalama Ticaret Kârlılığı

Ortalama ticari kârlılık, içeriden öğrenen tarafından son üç yılda yaptığı tüm açık piyasa alımlarının ortalama getirisidir. Bunu hesaplamak için, 10b5-1 ticaret planının bir parçası olarak işaretlenen tüm işlemler hariç, içeriden öğrenenlerin yaptığı her açık piyasa, planlanmamış satın almayı inceliyoruz. Daha sonra bu işlemlerin 3, 6 ve 12 aylık ortalama performansını hesaplıyoruz ve her bir işlem için nihai bir performans ölçüsü oluşturmak amacıyla bu sürelerin her birinin ortalamasını alıyoruz. Son olarak, içeriden öğrenenlerin performans ölçümünü hesaplamak için tüm performans ölçümlerinin ortalamasını alıyoruz. Bu liste yalnızca son iki yılda en az üç işlem gerçekleştiren içeriden öğrenenleri içermektedir.

İçeriden öğrenenlerin ticari kârlılığı "Uygulanamaz" ise, içeriden öğrenen kişi ya son üç yılda herhangi bir açık piyasadan alım yapmamıştır ya da yaptıkları işlemler güvenilir bir performans ölçüsü hesaplamak için çok yenidir.

Güncelleme Sıklığı: Günlük

En kârlı içeriden öğrenen tüccarların listesine bakın.

İçeriden Öğrenen Pozisyonları Bildiren Şirketler

SEC dosyaları, Reshma Kewalramaniın aşağıdaki şirketlerde varlıkları olduğunu veya ticaret yaptığını bildirdiğini gösteriyor:

Menkul Kıymet Başlık Son Bildirilen Varlıklar
US:VRTX / Vertex Pharmaceuticals Incorporated CEO & President, Director 98.278
Director 186.002
Grafikler Nasıl Yorumlanır?

Aşağıdaki grafikler, Reshma Kewalramani tarafından yapılan her açık piyasa, planlanmamış ticaret sonrasında menkul kıymetlerin hisse senedi performansını göstermektedir. Planlanmamış ticaret, 10b5-1 ticaret planının parçası olarak yapılmayan ticarettir. Hisse senedi performansı, hisse fiyatındaki kümülatif yüzde değişim olarak gösterilmektedir. Örneğin, 1 Ocak 2019da içeriden öğrenen ticareti yapılmışsa grafik, menkul kıymetin günümüze kadar olan günlük yüzde değişimini gösterecektir. Bu süre zarfında hisse fiyatı 10 dolardan 15 dolara çıkarsa, hisse fiyatındaki kümülatif yüzde değişim %50 olacaktır. Fiyattaki 10 Dolardan 20 Dolara değişim %100, fiyatta 10 Dolardan 5 Dolara değişim ise -%50 olur.

Son olarak, içeriden öğrenenin işlemlerinin içeriden öğrenilen bilgilerden kâr elde edebilmek için zamanlayıp zamanlamadığını görmek amacıyla, içeriden öğrenenin işlemlerinin hisse fiyatındaki aşırı getirilerle (pozitif veya negatif) ne kadar yakından ilişkili olduğunu belirlemeye çalışıyoruz. İçeriden öğrenenin bunu yaptığı durumu düşünün. Bu durumda, (a) alımlardan sonra pozitif getiriler veya (b) satışlardan sonra olumsuz getiriler bekleriz. (a) durumunda, ALIM grafiği, her satın alma işleminden sonra pozitif getiriyi gösteren bir dizi yukarı doğru eğimli eğri gösterecektir. (b) durumunda, SATIM grafiği, her satış işleminden sonra negatif getiriyi gösteren bir dizi aşağı doğru eğimli eğri gösterecektir.

Ancak bu tek başına sonuç çıkarmak için yeterli değildir. Örneğin, şirketin hisse fiyatı uzun yıllar boyunca döngüsel olmayan bir yükseliş gösteriyorsa, satın alma sonrası tüm lotların yukarı doğru eğimli olmasını bekleriz. Benzer şekilde, uzun yıllar boyunca döngüsel olmayan düşüşler, ticaret sonrası lotların aşağı doğru eğimli olmasına neden olacaktır. Bu grafiklerin hiçbiri içeriden öğrenenlerin ticareti faaliyeti şüphesi öne sürmez.

En güçlü gösterge, hisse fiyatının son derece döngüsel olduğu ve ALIM tablosunda hem pozitif sinyallerin, hem de SATIM grafiğinde negatif lotların olduğu bir durum olacaktır. Bu durum, içeriden öğrenenin işlemleri kendi finansal avantajlarına göre zamanladığını gösteriyor.

İçeriden Öğrenen Ticareti Geçmişi

Bu tablo, Reshma Kewalramani tarafından Menkul Kıymetler Borsası Komisyonuna (SEC) açıklanan içeriden öğrenen ticaretinin tam listesini gösterir.

Dosya Tarihi İşlem Tarihi Form Ticker Menkul Kıymet Kod 10b5-1 Hisseler Kalan Hisseler Yüzde
Değişimi
Hisse
Fiyatı
İşlem
Değeri
Kalan
Değer
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.725 98.278 -1,72 496,95 -857.239 48.839.252
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.995 100.003 -5,66 496,16 -2.974.479 49.617.488
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.580 105.998 -12,81 495,38 -7.718.020 52.509.289
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.498 121.578 -2,80 494,33 -1.729.166 60.099.653
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.520 125.076 -1,97 493,29 -1.243.091 61.698.740
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -949 127.596 -0,74 491,30 -466.244 62.687.915
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.725 128.545 -2,08 490,54 -1.336.722 63.056.464
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -460 131.270 -0,35 489,32 -225.087 64.233.036
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.278 131.730 -2,43 488,27 -1.600.549 64.319.807
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.510 135.008 -1,83 487,13 -1.222.696 65.766.447
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 137.518 -0,17 482,84 -115.882 66.399.191
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 137.758 -0,09 481,50 -57.780 66.330.477
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 137.878 -0,29 479,75 -191.900 66.146.970
2026-02-26 2026-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4.981 138.278 -3,48 485,11 -2.416.333 67.080.041
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6.554 143.259 -4,37 483,75 -3.170.498 69.301.541
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 16.326 149.813 12,23
2026-02-18 2026-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -13.041 133.487 -8,90 487,76 -6.360.878 65.109.619
2026-02-12 2026-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.297 146.528 -5,36 468,41 -3.886.398 68.635.180
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11.885 154.825 8,31
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 142.940 23,26
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5.710 115.968 5,18 389,95 2.226.614 45.221.722
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.290 110.258 4,05 389,08 1.669.153 42.899.183
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -14.079 105.915 -11,73 479,61 -6.752.429 50.797.893
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 119.994 -7,25 483,28 -4.536.066 57.990.700
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6.553 129.380 -4,82 463,46 -3.037.053 59.962.455
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 19.015 135.933 16,26
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.300 116.918 -6,63 467,98 -3.884.234 54.715.286
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.328 125.218 19,38
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.118 104.890 38,43
2024-11-12 2024-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.198 75.772 -16,71 515,00 -7.826.970 39.022.580
2024-08-01 2024-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 90.970 -14,32 505,00 -7.677.010 45.939.850
2024-07-24 2024-07-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 106.172 -12,52 497,00 -7.555.394 52.767.484
2024-06-14 2024-06-12 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 105.263 186.002 130,37
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.565 121.374 -1,27 457,00 -715.205 55.467.918
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.565 122.939 1,29 187,53 293.484 23.054.751
2024-05-22 2024-05-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 121.374 -11,13 447,00 -6.795.294 54.254.178
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 136.507 -6,43 431,79 -4.052.781 58.942.358
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7.019 145.893 -4,59 420,58 -2.952.051 61.359.678
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.359 152.912 -5,77 424,01 -3.968.310 64.836.217
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.255 162.271 -4,84 422,74 -3.489.719 68.598.443
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.327 170.526 13,53
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 150.199 21,89
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14.516 123.227 13,35
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17.135 108.711 -13,62 407,00 -6.973.945 44.245.377
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 14.077 125.846 12,59 187,53 2.639.860 23.599.900
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.058 111.769 2,81 155,57 475.733 17.387.903
2023-12-15 2023-12-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.098 108.711 -4,48 397,00 -2.023.906 43.158.267
2023-11-15 2023-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.097 113.809 -4,29 377,00 -1.921.569 42.905.993
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.828 118.906 -6,18 355,00 -2.778.940 42.211.630
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -38 126.652 -0,03 340,19 -12.927 43.085.744
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.668 126.690 -1,30 339,43 -566.169 43.002.387
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.611 128.358 -1,24 338,69 -545.630 43.473.571
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 129.969 -6,74 289,12 -2.713.680 37.576.637
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.359 139.355 -6,29 292,85 -2.740.783 40.810.112
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -5.990 148.714 -3,87 298,26 -1.786.577 44.355.438
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.372 154.704 -2,13 294,33 -992.481 45.534.028
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 158.076 20,57
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.118 131.104 28,55
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.388 101.986 13,83
2023-01-27 2023-01-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 89.598 -10,04 315,05 -3.150.500 28.227.850
2022-11-10 2022-09-30 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 9.818 80.739 13,84
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.689 99.598 -10,50 305,06 -3.565.846 30.383.366
2022-06-28 2022-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.689 111.153 -9,52 291,30 -3.405.006 32.378.869
2022-06-13 2022-06-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
A - Award 70.921 70.921
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7.246 122.842 -5,57 227,86 -1.651.074 27.990.778
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.584 130.088 -6,19 232,51 -1.995.866 30.246.761
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.031 138.672 -2,14 237,74 -720.590 32.967.881
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.117 141.703 25,86
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.032 112.586 34,75
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.800 83.554 13,29
2021-11-23 2021-11-19 4 DNA Ginkgo Bioworks Holdings, Inc.
Restricted Stock Units
A - Award 9.818 9.818
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 17.649 17.649
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 51.782 51.782
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.243 73.754 6,10 196,34 833.071 14.480.860
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5.757 69.511 9,03 195,14 1.123.421 13.564.377
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.898 63.643 -4,36 217,57 -630.518 13.846.808
2021-02-19 2021-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.080 66.541 -3,03 211,75 -440.440 14.090.057
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.962 68.621 -4,14 214,16 -634.342 14.695.873
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.031 71.583 68,22
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.388 42.552 41,07
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.516 30.164 13,19
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 3.058 -14,27
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 15.642 -9,09
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -93 26.626 -0,35 273,27 -25.414 7.276.087
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -487 26.719 -1,79 272,76 -132.834 7.287.874
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -471 27.206 -1,70 271,42 -127.839 7.384.253
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -870 27.677 -3,05 270,36 -235.213 7.482.754
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -152 28.547 -0,53 269,11 -40.905 7.682.283
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 28.699 1,81 155,57 79.185 4.464.703
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.564 28.190 5,87 187,53 293.297 5.286.471
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26.626 -0,03 288,37 -2.595 7.678.140
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -19 26.635 -0,07 287,63 -5.465 7.661.025
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -27 26.654 -0,10 286,07 -7.724 7.624.910
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10 26.681 -0,04 283,76 -2.838 7.571.001
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4 26.691 -0,01 282,74 -1.131 7.546.613
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26.695 -0,02 281,74 -1.690 7.521.049
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26.701 -0,03 280,47 -2.524 7.488.829
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7 26.710 -0,03 279,70 -1.958 7.470.787
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26.717 -0,02 276,40 -1.658 7.384.579
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2 26.723 -0,01 274,37 -549 7.331.990
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 3.567 -12,51
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 17.206 -8,33
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 26.626 -0,50 275,17 -36.873 7.326.676
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -864 26.760 -3,13 274,04 -236.771 7.333.310
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 27.624 -1,29 272,77 -98.197 7.534.998
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 27.984 -1,06 271,92 -81.576 7.609.409
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -416 28.284 -1,45 270,35 -112.466 7.646.579
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 510 28.700 1,81 155,57 79.341 4.464.859
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.564 28.190 5,87 187,53 293.297 5.286.471
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -111 26.626 -0,42 239,13 -26.543 6.367.075
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -420 26.737 -1,55 238,28 -100.078 6.370.892
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -320 27.157 -1,16 236,71 -75.747 6.428.333
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -340 27.477 -1,22 235,36 -80.022 6.466.987
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -660 27.817 -2,32 234,41 -154.711 6.520.583
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -440 28.477 -1,52 232,35 -102.234 6.616.631
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -450 28.917 -1,53 230,88 -103.896 6.676.357
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -893 29.367 -2,95 229,72 -205.140 6.746.187
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.898 30.260 -8,74 239,23 -693.289 7.239.100
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 33.158 -0,39 245,75 -31.702 8.148.578
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -260 33.287 -0,78 244,94 -63.684 8.153.318
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 33.547 -0,40 243,76 -32.664 8.177.417
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -540 33.681 -1,58 242,62 -131.015 8.171.684
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 34.221 -0,35 241,71 -29.005 8.271.558
2020-02-19 2020-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -944 34.341 -2,68 241,50 -227.976 8.293.352
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 4.077 -11,12
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 18.770 -7,69
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 35.285 -0,36 242,47 -31.279 8.555.554
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -271 35.414 -0,76 240,75 -65.243 8.525.920
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -423 35.685 -1,17 239,69 -101.389 8.553.338
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.251 36.108 -3,35 238,76 -298.689 8.621.146
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -510 37.359 -1,35 155,57 -79.341 5.811.940
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -1.564 36.849 -4,07 187,53 -293.297 6.910.293
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.387 35.285 54,10
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.800 22.898 74,82
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy)
M - Exercise -4.692 20.334 -18,75
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.692 13.098 -26,37 219,37 -1.029.284 2.873.308
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.692 17.790 35,82 187,53 879.891 3.336.159
2019-11-19 2019-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -61 13.098 -0,46 205,95 -12.563 2.697.533
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 4.587 -9,99
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -509 13.098 -3,74 199,00 -101.291 2.606.502
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 13.607 3,89 155,57 79.185 2.116.841
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.057 5.096 -37,50
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.057 13.098 -18,92 199,00 -608.343 2.606.502
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.057 16.155 23,34 155,57 475.577 2.513.233
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -638 13.098 -4,64 189,00 -120.582 2.475.522
2019-05-17 2019-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -241 13.736 -1,72 165,41 -39.864 2.272.072
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 13.736 -0,72 188,49 -18.849 2.589.099
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -202 13.836 -1,44 187,27 -37.829 2.591.068
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.186 14.038 -7,79 186,75 -221.486 2.621.596
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 25.026 25.026
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.799 15.224 180,63
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.516 5.425 184,18
2018-10-09 2018-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.305 1.909 -54,70 186,95 -430.920 356.888
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3/A VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
4.214
P
Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel alımı
S
Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel satımı
A
Şirketten menkul kıymetlerin verilmesi, ödüllendirilmesi veya başka şekilde edinilmesi (opsiyon gibi)
C
Türevin dönüşümü
D
Menkul kıymetlerin şirkete geri satışı veya devri
F
Kullanım bedelinin veya vergi yükümlülüğünün şirketten alınan menkul kıymetlerin bir kısmı kullanılarak ödenmesi
G
Menkul kıymetlerin içeriden birine veya kişiye hediye edilmesi
K
Özkaynak swapları ve benzeri riskten korunma işlemleri
M
Şirketten alınan türev menkul kıymetin kullanılması veya dönüştürülmesi (opsiyon gibi)
V
Form 4te gönüllü olarak bildirilen bir işlem
J
Diğer (işlemi açıklayan bir dipnotla birlikte)